Two complementary studies led by researchers from the Yong Loo Lin School of Medicine, National University of Singapore (NUS Medicine), have demonstrated a new RNA-based therapeutic strategy that ...

Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such ...

At the Mayo Clinic, cardiologists Peter Noseworthy, M.D., and John Giudicessi, M.D., Ph.D., are uncovering the earliest signs ...

Taysha Gene Therapies Inc. (NASDAQ: TSHA) is a must-buy penny stock to buy now. On November 13, Piper Sandler analyst Biren ...

Benitec Biopharma Inc. (NASDAQ: BNTC) is one of the best breakout stocks to invest in. On November 4, an analyst at Citizens ...

Cincinnati Children's dedicated a new research center in Sharonville to finding treatments for patients with cancer, blood ...

The Food and Drug Administration shouldn’t be in the news if it’s doing its job right. By that measure the FDA is failing in spectacular fashion. The agency this week is making news for all of the ...

The US FDA has tightened the use of a Duchenne muscular dystrophy gene therapy after two teenage patients died from acute ...

RELATED: San Antonio family raises awareness, funds for baby diagnosed with ultra-rare disease Sunday they held “Hope for ...

In a major step forward for cancer care, researchers at ChristianaCare's Gene Editing Institute have shown that disabling the ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor ...

Beyond a cancer cell’s genetic blueprint, the expression levels of certain proteins on its surface is emerging as a collection of critical, actionable biomarkers. Instead of looking for a mutated gene ...